Results 31 to 40 of about 52,208 (254)

von Willebrand factor and inflammation [PDF]

open access: yesJournal of Thrombosis and Haemostasis, 2017
Von Willebrand factor (VWF) is a plasma glycoprotein best known for its crucial hemostatic role in serving as a molecular bridge linking platelets to subendothelial components following vascular injury. In addition, VWF functions as chaperone for coagulation factor VIII. In pathological settings, VWF is recognized as a risk factor for both arterial and
C, Kawecki, P J, Lenting, C V, Denis
openaire   +2 more sources

Macrophage scavenger receptor SR-AI contributes to the clearance of von Willebrand factor

open access: yesHaematologica, 2018
Previously, we found that LDL-receptor related protein-1 on macrophages mediated shear stress-dependent clearance of von Willebrand factor. In control experiments, however, we observed that von Willebrand factor also binds to macrophages independently of
Nikolett Wohner   +9 more
doaj   +1 more source

von Willebrand Disease: The diagnosis and management of this bleeding disorder

open access: yesMedical Journal of Babylon, 2020
von Willebrand disease (vWD) is one of the most common bleeding disorders, first described by Erik von Willebrand in the Aland Islands. It occurs as a result of decreased or abnormal von Willebrand factor (vWF), a factor that is needed in the process of ...
Basim A. Abd, Nawrass J Al-Salihi
doaj   +1 more source

Clearance of von Willebrand factor [PDF]

open access: yesThrombosis and Haemostasis, 2008
SummaryThe life cycle of von Willebrand factor (VWF) comprises a number of distinct steps, ranging from the controlled expression of theVWF gene in endothelial cells and megakaryocytes to the removal of VWF from the circulation. The various aspects of VWF clearance have been the objects of intense research in the last few years, stimulated by ...
Cécile V, Denis   +3 more
openaire   +2 more sources

Recombinant von Willebrand Factor for Pediatric Patient with von Willebrand Disease: First Report in Korea

open access: yesClinical Pediatric Hematology-Oncology, 2021
von Willebrand disease (VWD) is the most common hereditary bleeding disorder. The treatment of VWD consists mainly of desmopressin and plasma-derived von Willebrand factor (pd-VWF) concentrate.
Seoin Kim, Young Shil Park
doaj   +1 more source

Zebrafish von Willebrand factor [PDF]

open access: yesBlood Cells, Molecules, and Diseases, 2010
von Willebrand factor (vWF) is a large protein involved in primary hemostasis. A dysfunction in this protein or an insufficient production of the protein leads to improper platelet adhesion/aggregation, resulting in a bleeding phenotype known as von Willebrand disease (vWD).
Maira, Carrillo   +4 more
openaire   +2 more sources

Factor VIII/V C-domain swaps reveal discrete C-domain roles in factor VIII function and intracellular trafficking

open access: yesHaematologica, 2017
Factor VIII C-domains are believed to have specific functions in cofactor activity and in interactions with von Willebrand factor. We have previously shown that factor VIII is co-targeted with von Willebrand factor to the Weibel-Palade bodies in blood ...
Eduard H.T.M. Ebberink   +7 more
doaj   +1 more source

The role of von Willebrand factor in determining the risk of ischemic stroke in Hawler city: a case-control study [PDF]

open access: yesZanco Journal of Medical Sciences, 2018
Background and objective: Ischemic stroke is classically characterized as a neurological deficit attributed to an acute focal injury of the central nervous system by a vascular cause, it occurs as a result of obstruction by a blood clot (thrombus) or ...
Sazgar Anwar Hameed, Salar Adnan Ahmed
doaj   +1 more source

Clearance of von Willebrand factor [PDF]

open access: yesJournal of Thrombosis and Haemostasis, 2013
Quantitative deficiencies in von Willebrand factor (VWF) are associated with abnormal hemostasis that can manifest in bleeding or thrombotic complications. Consequently, many studies have endeavored to elucidate the mechanisms underlying the regulation of VWF plasma levels. This review focuses on the role of VWF clearance pathways.
C, Casari   +4 more
openaire   +2 more sources

Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia

open access: yesTherapeutic Advances in Hematology, 2021
The pathological increase of clonal IgM in Waldenström macroglobulinemia can be associated with acquired von Willebrand syndrome and can be a major risk of bleeding symptoms in this subgroup of patients with Waldenström macroglobulinemia.
María Poza   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy